We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
5vo2
From Proteopedia
(Difference between revisions)
m (Protected "5vo2" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 5vo2 is ON HOLD | + | The entry 5vo2 is ON HOLD until Paper Publication |
Authors: HARRIS, S.F., YIN, J. | Authors: HARRIS, S.F., YIN, J. | ||
| Line 7: | Line 7: | ||
Description: DLK in complex with inhibitor 5-(1-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (compound 7) | Description: DLK in complex with inhibitor 5-(1-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (compound 7) | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
| - | [[Category: Harris, S.F]] | ||
[[Category: Yin, J]] | [[Category: Yin, J]] | ||
| + | [[Category: Harris, S.F]] | ||
Revision as of 14:08, 27 September 2017
Unreleased structure
The entry 5vo2 is ON HOLD until Paper Publication
Authors: HARRIS, S.F., YIN, J.
Description: DLK in complex with inhibitor 5-(1-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (compound 7)
